Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial

BACKGROUND: Approximately 10%–15% of people with diabetes develop at least one foot ulcer during their lifetime. Treatment of diabetic foot ulcers (DFUs) represents a significant economic burden. Enzymatic debridement with clostridial collagenase ointment (CCO) can be used to remove necrotic tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Motley, Travis A, Gilligan, Adrienne M, Lange, Darrell L, Waycaster, Curtis R, Dickerson, Jaime E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357050/
https://www.ncbi.nlm.nih.gov/pubmed/25767565
http://dx.doi.org/10.1186/s13047-015-0065-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357050/
https://www.ncbi.nlm.nih.gov/pubmed/25767565
http://dx.doi.org/10.1186/s13047-015-0065-x

Ejemplares similares